BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35838205)

  • 21. The utility of peritoneal biopsy and omentectomy in the upstaging of apparent early ovarian cancer.
    Shroff R; Brooks RA; Zighelboim I; Powell MA; Thaker PH; Mutch DG; Massad LS
    Int J Gynecol Cancer; 2011 Oct; 21(7):1208-12. PubMed ID: 21633295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
    Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
    Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary ovarian mucinous adenocarcinoma of intestinal type: a clinicopathologic study of 46 cases.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Siriaunkgul S
    Int J Gynecol Pathol; 2014 Mar; 33(2):176-85. PubMed ID: 24487473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is lymphadenectomy necessary in mucinous ovarian cancer? A single institution experience.
    Salgado-Ceballos I; Ríos J; Pérez-Montiel D; Gallardo L; Barquet-Muñoz S; Salcedo-Hernández R; Pérez-Plasencia C; Herrera LA; Cantú de León DF
    Int J Surg; 2017 May; 41():1-5. PubMed ID: 28315410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature.
    Ludwick C; Gilks CB; Miller D; Yaziji H; Clement PB
    Int J Gynecol Pathol; 2005 Jul; 24(3):205-17. PubMed ID: 15968194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013.
    Prat J
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):858-69. PubMed ID: 25890882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study.
    Simons M; Ezendam N; Bulten J; Nagtegaal I; Massuger L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1208-15. PubMed ID: 25978291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.
    Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Tsuda H; Takano M
    J Ovarian Res; 2021 Feb; 14(1):33. PubMed ID: 33583413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
    Rodríguez IM; Prat J
    Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
    Firat Cuylan Z; Karabuk E; Oz M; Turan AT; Meydanli MM; Taskin S; Sari ME; Sahin H; Ulukent SC; Akbayir O; Gungorduk K; Gungor T; Kose MF; Ayhan A
    J Ovarian Res; 2018 Oct; 11(1):91. PubMed ID: 30376858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
    Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Suzuki R; Sato K; Tsuda H; Takano M
    Medicine (Baltimore); 2021 Aug; 100(32):e26895. PubMed ID: 34397915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
    Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():214-223. PubMed ID: 30905627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staging procedures in patients with mucinous borderline tumors of the ovary do not reveal peritoneal or omental disease.
    De Decker K; Speth S; Ter Brugge HG; Bart J; Massuger LFAG; Kleppe M; Kooreman LFS; Kruitwagen RFPM; Kruse AJ
    Gynecol Oncol; 2017 Feb; 144(2):285-289. PubMed ID: 27889017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
    Zeppernick F; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2014 Nov; 290(5):839-42. PubMed ID: 25082067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical staging of apparent early-stage ovarian mucinous carcinoma.
    Yuan Z; Zhang Y; Cao D; Shen K
    World J Surg Oncol; 2022 Sep; 20(1):307. PubMed ID: 36153622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving population-based statistics for rare epithelial ovarian cancers.
    Matsuo K; Machida H; Matsuzaki S; Grubbs BH; Klar M; Roman LD; Sood AK; Gershenson DM; Wright JD
    Gynecol Oncol; 2020 Apr; 157(1):3-11. PubMed ID: 31954534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Random peritoneal biopsies have limited value in staging of apparent early stage epithelial ovarian cancer after thorough exploration.
    Powless CA; Bakkum-Gamez JN; Aletti GD; Cliby WA
    Gynecol Oncol; 2009 Oct; 115(1):86-89. PubMed ID: 19631972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.